Global X China Biotech Innovation ETF is a ETF series of GLOBAL X FUNDS (series S000069671). Net assets $2.3M as of 2023-11-30. Index fund.
Showing 15 of 44 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Chongqing Zhifei Biological Products Co Ltd | — | $196K | 852.71% |
| CSPC PHARMACEUTICAL GROUP LIMITED | — | $192K | 834.11% |
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | — | $191K | 831.31% |
| WUXI BIOLOGICS (CAYMAN) INC. | — | $155K | 675.15% |
| Walvax Biotechnology Co., Ltd. | — | $144K | 625.81% |
| Beijing Tiantan Biological Products Corporation Limited | — | $113K | 491.98% |
| Shanghai RAAS Blood Products Co., Ltd. | — | $113K | 490.87% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | — | $104K | 451.02% |
| HUALAN BIOLOGICAL ENGINEERING, INC. | — | $99K | 431.66% |
| Genscript Biotech Corp | — | $96K | 416.61% |
| Zai Lab Ltd | — | $86K | 375.59% |
| Shenzhen Kangtai Biological Products Co.,Ltd. | — | $79K | 342.48% |
| BGI Genomics Co., Ltd. | — | $58K | 254.52% |
| 3SBio Inc. | — | $53K | 228.60% |
| Anhui Huaheng Biotechnology Co Ltd | — | $48K | 207.45% |
| Report date | Net assets |
|---|---|
| 2023-11-30 | $2.3M |
| 2023-08-31 | $2.0M |
| 2023-05-31 | $2.2M |
| 2023-02-28 | $2.6M |
| 2022-11-30 | $2.6M |
| 2022-08-31 | $2.7M |
| 2022-05-31 | $2.6M |
| 2022-02-28 | $3.3M |